Medication Fact Sheets
|
November 29, 2024

Guanfacine: Dosage, Uses, Risks, and Alternatives

Written By
Medically Reviewed by
Updated On
December 4, 2024

Staying focused and managing emotions can be difficult for many people, especially when life feels overwhelming. Guanfacine is a medication that may help by supporting calmness and self-control. It works differently than other medications and is often used for specific concerns related to attention and behavior.

This article will explain how guanfacine works, its uses, possible side effects, and alternatives to consider. Whether you're learning for yourself or a loved one, this guide will provide clear and helpful information.

[signup]

What is Guanfacine?

Guanfacine is a prescription medication primarily known for its calming effects on the brain and body. It belongs to a class of drugs called alpha-2A adrenergic receptor agonists, which help regulate nerve activity. 

Originally approved to manage high blood pressure (hypertension), guanfacine is now commonly prescribed for conditions like Attention-Deficit/Hyperactivity Disorder (ADHD). Its ability to reduce hyperactivity, impulsivity, and improve focus has made it a valuable option for many patients.

History and Development

1974: Guanfacine was first approved by the U.S. Food and Drug Administration (FDA) as a treatment for high blood pressure. Its role in managing hypertension is tied to its ability to relax blood vessels and lower overall pressure in the cardiovascular system.

2009: After further research, guanfacine became FDA-approved for ADHD under the brand name Intuniv. This marked its transition from a hypertension treatment to a tool for managing behavioral and cognitive symptoms.

2010s to Today: Guanfacine is now widely used off-label for other conditions where calming the central nervous system is beneficial, including anxiety and certain sleep disturbances. Studies continue to explore its effects on different neurological and psychiatric conditions.

How Guanfacine Works (Mechanism of Action)

Guanfacine works by stimulating alpha-2A adrenergic receptors in the brain, particularly in the prefrontal cortex. This part of the brain is responsible for attention, impulse control, and emotional regulation. By activating these receptors, guanfacine strengthens connections between brain cells and improves signal transmission in the prefrontal cortex.

Physiological Effects

  • Reduces Nerve Overactivity: By calming excessive signals in the nervous system, guanfacine promotes a sense of calm and focus.
  • Improves Prefrontal Cortex Functioning: This helps with regulating emotions, managing impulses, and staying focused on tasks.

Impact on ADHD Patients

For individuals with ADHD, guanfacine may help reduce symptoms like hyperactivity and impulsivity while improving attention span. It achieves these effects without directly stimulating the brain, which differentiates it from stimulant medications like Ritalin or Adderall.

By balancing the central nervous system, guanfacine supports better overall functioning in both children and adults with ADHD.

Uses and Benefits of Guanfacine

Guanfacine is a versatile medication that helps manage a range of conditions by calming overactive nerve signals. Its primary use is in ADHD treatment, but it also has applications for other conditions like anxiety, PTSD, and hypertension.

Guanfacine for ADHD

Guanfacine is often prescribed as an alternative to stimulant medications or as an additional treatment alongside them. Unlike stimulants like Ritalin or Adderall, guanfacine does not increase dopamine activity directly. Instead, it works on alpha-2A adrenergic receptors in the brain to improve focus, reduce hyperactivity, and enhance impulse control.

Efficacy for ADHD Symptoms

  • Impulsivity: Guanfacine helps individuals pause and think before acting, making it easier to regulate responses.
  • Hyperactivity: By calming the nervous system, guanfacine reduces restlessness and overactive behaviors.
  • Inattention: Improved function of the prefrontal cortex allows for better focus and sustained attention.

Use as Adjunct Therapy

For individuals who experience side effects from stimulants or need additional symptom management, guanfacine can complement stimulant therapy. It helps balance overstimulation and improves sleep, which is often disrupted in people with ADHD.

Other conditions treated with Guanfacine include:

  • Anxiety and Stress-Related Disorders: Guanfacine’s calming effects on the nervous system make it useful for managing anxiety and conditions like post-traumatic stress disorder (PTSD). It helps regulate emotional responses and reduce overactivation of the "fight or flight" system.
  • High Blood Pressure (Hypertension): As its original FDA-approved use, guanfacine lowers blood pressure by relaxing blood vessels and reducing the workload on the heart. This is still a viable option for individuals who need mild blood pressure control.
  • Other Uses (Off-Label): Guanfacine may also be prescribed to improve sleep quality or manage symptoms of autism spectrum disorder (ASD), although more research is needed to confirm its effectiveness in these areas.

Dosage and Administration Guidelines

Proper dosage and careful administration of guanfacine are essential for its effectiveness and safety. The dosage varies depending on the patient’s age, condition, and how they respond to the medication.

For ADHD

  • Children (Ages 6–12): Typically, the starting dose is 1 mg taken once daily. The dose may be increased gradually by 1 mg per week based on the patient’s response and tolerance. The maximum recommended dose is 4 mg per day.
  • Adolescents (Ages 13–17): Similar to children, the starting dose is 1 mg daily, with gradual increases up to a maximum of 7 mg per day, depending on individual needs and tolerance.
  • Adults: While guanfacine is less commonly used for adults with ADHD, the dosage ranges from 1–7 mg daily, depending on the patient’s response.

For Hypertension

  • Adults: The usual starting dose is 1 mg at bedtime. The dose can be increased as needed, typically in increments of 1 mg, up to a maximum of 3 mg daily.

Dosage Adjustments

Patients with kidney or liver issues may need lower doses due to slower medication processing.

Always follow the prescribing doctor’s instructions, as adjustments are made based on the individual’s response and side effects.

Administration Tips and Best Practices

  • Time of Day: Guanfacine is usually taken at bedtime to minimize drowsiness during the day. If prescribed for twice-daily use, space doses evenly.
  • With or Without Food: Guanfacine can be taken with or without food. If it causes stomach upset, taking it with a light meal may help.
  • Consistency is Key: Take guanfacine at the same time each day to maintain steady levels in the body. Missing doses can reduce its effectiveness or cause withdrawal-like symptoms.
  • Avoid Sudden Stopping: Abruptly discontinuing guanfacine can lead to a sudden rise in blood pressure or other withdrawal effects. If stopping is necessary, taper the dose gradually under medical supervision.

Overdose Risks and What to Do

An overdose of guanfacine can cause:

Emergency Steps to Take

  • Immediate Action: Call emergency services or the Poison Control Center at 1-800-222-1222 in the U.S.
  • Stay Calm: Keep the patient awake and monitor breathing and pulse until help arrives.
  • Bring Medication Information: Provide responders with the medication name, dosage, and any other medications being taken.

Potential Side Effects of Guanfacine

While guanfacine is generally well-tolerated, it may cause side effects in some people. These can range from mild to severe, so it’s important to understand what to watch for and how to respond.

Common Side Effects

Mild side effects are more likely to occur during the first weeks of use as the body adjusts. These include:

Serious Side Effects and Risks

Severe side effects are less common but require immediate attention. These include:

  • Low Blood Pressure (Hypotension): Symptoms such as dizziness, fainting, or feeling lightheaded.
  • Heart Issues: Slow heart rate (bradycardia) or irregular heartbeat.
  • Withdrawal Symptoms: Stopping guanfacine abruptly may lead to a sudden spike in blood pressure or increased nervousness and agitation.

How to Manage Side Effects

For mild side effects:

  • Drowsiness or Fatigue: Take the medication at bedtime to reduce daytime drowsiness.
  • Dry Mouth: Drink plenty of water, chew sugar-free gum, or use an oral moisturizer.
  • Constipation: Increase fiber intake and stay hydrated to promote regular bowel movements.
  • Headache: Over-the-counter pain relief like acetaminophen may help, but consult your doctor before using it.

When to consult a doctor:

  • If drowsiness, headaches, or other mild symptoms persist or worsen.
  • If you experience dizziness, fainting, or chest pain.
  • If withdrawal symptoms occur after missing a dose or stopping the medication.

Side Effect Chart

Comparing Guanfacine with Other ADHD Medications

ADHD medications can be broadly categorized into stimulant and non-stimulant options. Guanfacine, a non-stimulant, works differently than stimulant medications like Adderall. Understanding these differences and potential combinations can help in finding the best approach for symptom management.

Stimulant Medications (e.g., Adderall, Ritalin):

  • Mechanism of Action: Stimulants work by increasing dopamine and norepinephrine levels in the brain, which helps improve focus and reduce impulsivity.
  • Efficacy: Highly effective for most individuals with ADHD, offering fast symptom relief.
  • Side Effects: Common side effects include insomnia, appetite suppression, and jitteriness. They may also cause anxiety or exacerbate tics.
  • Appropriateness: Generally recommended as a first-line treatment for ADHD but may not be suitable for individuals with heart issues, anxiety, or a history of substance misuse.

Non-Stimulant Medications (e.g., Guanfacine):

  • Mechanism of Action: Guanfacine calms overactive nerve signals by stimulating alpha-2A adrenergic receptors, improving prefrontal cortex function.
  • Efficacy: Effective for reducing hyperactivity, impulsivity, and emotional dysregulation. It may be slower-acting than stimulants but is ideal for patients sensitive to stimulant side effects.
  • Side Effects: Includes drowsiness, fatigue, and low blood pressure, which are generally milder than stimulant-related side effects.
  • Appropriateness: A good option for individuals who cannot tolerate stimulants or need additional symptom management.

Alternatives to Guanfacine

Here are examples of alternatives to Guanfacine

Atomoxetine (Strattera):

  • Pros: Non-stimulant; Atomoxetine works by increasing norepinephrine levels. It is effective for improving focus and impulse control without causing stimulant-related side effects.
  • Cons: May take several weeks to show effects. Common side effects include nausea, fatigue, and a slight risk of mood changes.

Clonidine:

  • Pros: Like guanfacine, clonidine is an alpha-2 adrenergic receptor agonist, useful for calming hyperactivity and helping with sleep issues.
  • Cons: It has more sedative effects than guanfacine, which may limit its daytime use. Side effects include drowsiness and low blood pressure.

Other Options

Behavioral therapy and lifestyle changes (such as exercise and structured routines) are often recommended alongside or instead of medications, depending on the individual's needs.

Guanfacine in Combination Therapy

In some cases, guanfacine is combined with stimulant medications for more comprehensive ADHD management. This approach is particularly helpful for individuals who:

  • Struggle with emotional regulation or hyperactivity despite taking stimulants.
  • Experience stimulant-related side effects, such as insomnia or anxiety, which guanfacine can help counteract.
  • Need additional support for calming the nervous system and improving sleep.

For example, a patient may take a stimulant like Adderall during the day to enhance focus and guanfacine at night to promote relaxation and address residual symptoms. Combination therapy should always be guided by a healthcare provider to monitor for interactions and optimize benefits.

Long-Term Use and Safety of Guanfacine

Guanfacine is increasingly prescribed for long-term management of ADHD and other conditions, raising questions about its safety over extended periods. Current research and clinical experience suggest that guanfacine is generally safe, but like all medications, it has potential risks that need careful consideration.

Tolerance, Dependence, and Withdrawal Concerns

Guanfacine is not habit-forming in the way that stimulant medications can be. However, stopping the medication abruptly may lead to withdrawal symptoms, particularly a rebound increase in blood pressure or heightened nervousness.

  • Tolerance: The body does not typically develop tolerance to guanfacine’s therapeutic effects, meaning the dose does not need frequent increases over time.
  • Dependence: Although physical dependence is rare, the body may adjust to the medication, requiring a gradual tapering process to avoid withdrawal effects.
  • Withdrawal Symptoms: These may include rapid heart rate, agitation, or increased blood pressure. To minimize these risks, a healthcare provider should create a tapering schedule when discontinuing guanfacine.

Is Guanfacine Safe for Children?

Guanfacine is FDA-approved for children as young as six years old, primarily for ADHD. Long-term use in children has shown safety and effectiveness when managed properly, but there are specific considerations:

  • Age-Specific Risks: Children may be more prone to drowsiness, fatigue, and low blood pressure. Regular monitoring of these symptoms is essential to ensure safety.
  • Developmental Considerations: Research suggests guanfacine does not negatively impact growth or development when used appropriately. However, parents and caregivers should work closely with healthcare providers to monitor behavior, sleep patterns, and overall development.
  • Sleep Benefits: Guanfacine’s sedative effects can improve sleep, which is often disrupted in children with ADHD, supporting overall health and development.

How to Discuss Guanfacine with Your Doctor

alking openly with your doctor is an important step when considering guanfacine as a treatment option. Being prepared with questions and a clear understanding of your needs can help ensure that the treatment aligns with your goals and lifestyle.

Questions to Ask About Guanfacine

  • What are the benefits of guanfacine for my symptoms or condition?
  • How does guanfacine compare to other medications I could take?
  • What side effects should I expect, and how can they be managed?
  • Is guanfacine safe with my current medications or health conditions?
  • How long will it take to see improvements, and how will we track progress?
  • If I want to stop taking guanfacine, what is the safest way to do so?

Assessing Your Needs and Goals

Before your appointment, think about your treatment goals and any personal factors that could affect your response to guanfacine.

  • Symptom Prioritization: Identify which symptoms, such as hyperactivity, impulsivity, or difficulty sleeping, are most important for you to address.
  • Mental Health History: Share your experience with previous medications, therapies, or treatments, including what has or hasn’t worked in the past.
  • Lifestyle Considerations: Discuss your daily schedule, sleep patterns, and responsibilities to determine the best dosing plan. For example, if drowsiness is a concern, your doctor might recommend taking guanfacine at night.

Next Steps for Potential Guanfacine Users

If your doctor recommends trying guanfacine, here’s what to expect:

  • Starting a Trial: Your doctor will likely begin with a low dose, increasing it gradually to find the most effective amount with minimal side effects.
  • Monitoring Symptoms: Keep a log of your symptoms, any changes, and side effects. Note improvements in areas like focus, sleep, or emotional regulation.
  • Regular Check-Ins: Schedule follow-ups to discuss how guanfacine is working. Your doctor may adjust the dose or explore other options based on your experience.

[signup]

Key Takeaways

  • Guanfacine is primarily used for ADHD, calming overactive nerve signals in the brain to improve focus, impulse control, and emotional regulation.
  • Dosages typically start at 1 mg daily, increasing gradually to a maximum of 4–7 mg depending on age and response to treatment.
  • Common side effects include drowsiness, fatigue, and low blood pressure, with rare but serious risks such as withdrawal symptoms or heart irregularities requiring medical attention.
  • Unlike stimulant medications, guanfacine is non-addictive, slower-acting, and better suited for individuals sensitive to stimulant-related side effects.
  • Alternatives include atomoxetine and clonidine, while guanfacine is often combined with stimulants to enhance emotional regulation and improve sleep quality.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Advokat, C., & Scheithauer, M. (2013). Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. Frontiers in Neuroscience, 7(82). https://doi.org/10.3389/fnins.2013.00082

Arnsten, A. F. T. (2020). Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiology of Learning and Memory, 176, 107327. https://doi.org/10.1016/j.nlm.2020.107327

Authors, Jahagirdar, D., & Mahood, Q. (2022). Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder: Rapid Review. In PubMed. Canadian Agency for Drugs and Technologies in Health. https://www.ncbi.nlm.nih.gov/books/NBK603607/

Bernknopf, A. (2011). Guanfacine (Intuniv) for Attention-Deficit/Hyperactivity Disorder. American Family Physician, 83(4), 468–475. https://www.aafp.org/pubs/afp/issues/2011/0215/p468.html

Bryant, A. (2024a, August 2). Understanding Arrhythmias: Types, Symptoms, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/arrhythmias-basics-types-symptoms-diagnosis-treatment

Bryant, A. (2024b, October 25). Lab Tests for Patients with Dry Mouth and Eyes. Rupa Health. https://www.rupahealth.com/post/lab-tests-for-patients-with-dry-mouth-and-eyes

C. Zamboulis, & Reid, J. L. (1981). Withdrawal of guanfacine after long-term treatment in essential hypertension. European Journal of Clinical Pharmacology, 19(1), 19–24. https://doi.org/10.1007/bf00558376

Cheng, C., Mehta, S., & Chai, G. (2017). Pediatric Postmarketing Pharmacovigilance and Drug Utilization Review Drug Use Analyst:-FDA personnel without contractor approval obtained through the FDA/CDER Office of Surveillance and Epidemiology.**. https://www.fda.gov/media/164281/download

Clemow, D. B., Bushe, C., Mancini, M., Ossipov, M. H., & Upadhyaya, H. (2017). A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatric Disease and Treatment, 13, 357–371. https://doi.org/10.2147/NDT.S115707

Cloyd, J. (2023a, March 7). An integrative medicine approach to fatigue. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue

Cloyd, J. (2023b, May 17). A Functional Medicine Constipation Protocol: Testing, Nutrition, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-constipation-protocol-testing-nutrition-and-supplements

Cloyd, J. (2023c, September 28). Integrative medicine approach to treating hypotension. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-approach-to-treating-hypotension

Cloyd, J. (2024a, January 8). The Science of Hydration: How Water Intake Affects Overall Health. Rupa Health. https://www.rupahealth.com/post/the-science-of-hydration-how-water-intake-affects-overall-health

Cloyd, J. (2024b, August 29). High Blood Pressure: Comprehensive Guide for Practitioners and Patients. Rupa Health. https://www.rupahealth.com/post/high-blood-pressure-comprehensive-guide-for-practitioners-and-patients

Connor, D. F., Grasso, D. J., Slivinsky, M. D., Pearson, G. S., & Banga, A. (2013). An Open-Label Study of Guanfacine Extended Release for Traumatic Stress Related Symptoms in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology, 23(4), 244–251. https://doi.org/10.1089/cap.2012.0119

Cruz, M. P. (2010). Guanfacine Extended-Release Tablets (Intuniv), a Nonstimulant Selective Alpha2A-Adrenergic Receptor Agonist For Attention-Deficit/Hyperactivity Disorder. Pharmacy and Therapeutics, 35(8), 448. https://pmc.ncbi.nlm.nih.gov/articles/PMC2935643/

Daglis, S. (2024, August 7). Tachycardia: Don’t Let Your Heart Run Away with You. Rupa Health. https://www.rupahealth.com/post/tachycardia-dont-let-your-heart-run-away-with-you

Dupont, A. G., Vanderniepen, P., & Six, R. O. (1987). Effect of guanfacine on ambulatory blood pressure and its variability in elderly patients with essential hypertension. British Journal of Clinical Pharmacology, 23(4), 397–401. https://doi.org/10.1111/j.1365-2125.1987.tb03068.x

Elbe, D., & Reddy, D. (2014). Focus on Guanfacine Extended-release: A Review of its Use in Child and Adolescent Psychiatry. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 23(1), 48. https://pmc.ncbi.nlm.nih.gov/articles/PMC3917669/

Fitzgerald, K. T., & Bronstein, A. C. (2013). Adderall® (amphetamine-dextroamphetamine) toxicity. Topics in Companion Animal Medicine, 28(1), 2–7. https://doi.org/10.1053/j.tcam.2013.03.002

Gerriets, V., & Nappe, T. M. (2024, January 11). Acetaminophen. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482369/

Giovannitti, J. A., Thoms, S. M., & Crawford, J. J. (2015). Alpha-2 Adrenergic Receptor Agonists: a Review of Current Clinical Applications. Anesthesia Progress, 62(1), 31–38. https://doi.org/10.2344/0003-3006-62.1.31

Guanfacine. (2012). PubMed; National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/NBK548586/

Guanfacine: MedlinePlus Drug Information. (n.d.). Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a601059.html

Kresge, K. (2023, March 2). An Integrative Medicine Approach to ADHD. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-adhd

Kumar Budur, Mathews, M., Adetunji, B., Mathews, M., & Mahmud, J. (2005). Non-Stimulant Treatment for Attention Deficit Hyperactivity Disorder. Psychiatry (Edgmont), 2(7), 44. https://pmc.ncbi.nlm.nih.gov/articles/PMC3000197/

Maholy, N. (2023, February 17). A functional medicine approach to anxiety: Testing, nutrition, & supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-anxiety

McCracken, J. T., McGough, J. J., Loo, S. K., Levitt, J., Del’Homme, M., Cowen, J., Sturm, A., Whelan, F., Hellemann, G., Sugar, C., & Bilder, R. M. (2016). Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. Journal of the American Academy of Child & Adolescent Psychiatry, 55(8), 657-666.e1. https://doi.org/10.1016/j.jaac.2016.05.015

Mechler, K., Banaschewski, T., Hohmann, S., & Häge, A. (2022). Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacology & Therapeutics, 230(230), 107940. https://doi.org/10.1016/j.pharmthera.2021.107940

Mishra, S., Shekunov, J., Derscheid, D. J., Canterbury, E. A., & Leung, J. G. (2022). Delayed Signs and Symptoms of Extended Release Guanfacine Overdose in Two Adolescent Patients: Implications of Monitoring on the Psychiatry Unit. Case Reports in Psychiatry, 2022, e2149301. https://doi.org/10.1155/2022/2149301

Neibling, K. (2023, February 27). Integrative medicine treatment for headaches. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-treatment-for-headaches

PubChem. (n.d.). Guanfacine. Pubchem.ncbi.nlm.nih.gov. https://pubchem.ncbi.nlm.nih.gov/compound/Guanfacine

Rocha, N. S., Correa, R. do E. S. A., Dias, A. C. de M., & Bueno, C. D. F. (2023). Association between sleep pattern and pharmacological treatment in children with attention deficit disorder with hyperactivity: a systematic review. Revista Paulista de Pediatria, 41, e2022065. https://doi.org/10.1590/1984-0462/2023/41/2022065

Storebø, O. J., Pedersen, N., Ramstad, E., Kielsholm, M. L., Nielsen, S. S., Krogh, H. B., Moreira-Maia, C. R., Magnusson, F. L., Holmskov, M., Gerner, T., Skoog, M., Rosendal, S., Groth, C., Gillies, D., Buch Rasmussen, K., Gauci, D., Zwi, M., Kirubakaran, R., Håkonsen, S. J., & Aagaard, L. (2018). Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews, 5(5). https://doi.org/10.1002/14651858.cd012069.pub2

Sweetnich, J. (2023, June 8). Integrative Treatment Options for The Most Common Pulmonary Disorders: Specialty Testing, Nutrition, Supplements. Rupa Health. https://www.rupahealth.com/post/integrative-treatment-options-for-the-most-common-pulmonary-disorders-specialty-testing-nutrition-supplements

Woolley, B. (2023). Growing off-Label Neuro-Cognitive Uses for Guanfacine? An Informal Review of Publications from 2022 with Discussion about Two Clinical Trials Scheduled to Conclude in 2023–2024. Issues in Mental Health Nursing, 44(9), 923–925. https://doi.org/10.1080/01612840.2023.2242236

Yasaei, R., & Saadabadi, A. (2022). Clonidine. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/29083638/

Yoshimura, H. (2023, November 7). The remarkable power of exercise on our health: A comprehensive overview. Rupa Health. https://www.rupahealth.com/post/the-remarkable-power-of-exercise-on-our-health-a-comprehensive-overview

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.